Telehealth company LifeMD accused of risky GLP-1 prescribing

Former employees of telehealth provider LifeMD claim the company pressured clinicians to quickly prescribe weight loss drugs, including GLP-1s, without proper screening or follow-up. This raises concerns about patient safety and the responsible rollout of high-demand medications. Novo Nordisk previously touted LifeMD as a partner.